<DOC>
	<DOCNO>NCT00863343</DOCNO>
	<brief_summary>The primary objective study evaluate performance MSDÂ® Influenza Test detect influenza A influenza B subject present influenza-like-illness ( ILI ) .</brief_summary>
	<brief_title>Clinical Validation Point-of-Care MSD Influenza Test</brief_title>
	<detailed_description>This multicenter , prospective study evaluate performance MSD Influenza Test detection differentiation influenza A ( include A/H1 , A/H3 , A/H5 subtypes ) influenza B. Nasal swabs subject present clinical care facility ILI collect tested MSD Influenza Test . Results Test compare result obtain viral culture perform second nasal swab reference laboratory .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Any subject ( age ) present ILI ( define fever [ subjective document ] cough sore throat ) , suspect influenza . Subject ( parent , guardian , authorized legal representative ) give informed consent assent ( child ) study , provide signed authorization use disclosure protect health information . Any subject classify `` high risk '' exposure avian novel influenza , determine RiskAssessment Questionnaire . Subjects prior nasal wash/aspirate nasopharyngeal wash/aspirate specimen collect routine healthcare purpose within suspect influenza infection episode .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Influenza infection</keyword>
	<keyword>Orthomyxoviridae infection</keyword>
</DOC>